Catalyst Wire Dossier Catalyst Wire Dossier

QUAZEPAM

QUAZEPAM · Atland Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for QUAZEPAM, covering 2007-10-30 to 2023-01-13. Get the full timeline:

Most recent: FDA Approved: QUAZEPAM — Supplemental Application (Atland Pharmaceuticals, LLC)

See pricing